Johnson & Johnson Named No. 1 Pharmaceutical Company by Fortune

Johnson & Johnson is a Hall of Fame company.


Johnson & Johnson has been named one of the World’s Most Admired Companies in 2023 by Fortune Magazine and has ranked No. 1 in the Pharmaceutical Industry.

Fortune collaborated with Korn Ferry to evaluate the performance and reputations of 645 companies across 27 countries. These companies were chosen from an original pool of 1,500 companies: The 1,000 largest companies in the U.S. ranked by revenue and non-U.S. companies in Fortune’s Global 500 database with a revenue of $10 billion or more.

The 50 All-Stars were determined by 3,760 executives, directors and securities analysts choosing the top 10 companies they admired the most. Leaders in the 52 industries were chosen based on nine criteria: ability to attract and retain talented people; quality of management; social responsibility to the community and the environment; innovativeness; quality of products or services; wise use of corporate assets; financial soundness; long-term investment value; and effectiveness in doing business globally.

This marks the 10th consecutive year ranking No. 1 in Pharmaceuticals and the 21st consecutive year that the pharmaceutical company has earned placement on the All-Stars list.

“The recognition is particularly rewarding since much of the judging criteria aligns with values outlined in Our Credo, Johnson & Johnson’s guiding mission statement,” the company said. “For example: ‘We are responsible to the communities in which we live and work and to the world community as well.'”


Join Our Newsletter

Get the top DEI news delivered straight to your inbox